Sharing My Routine – Hope It Helps Someone Else Too 7/2/2025
The conversation discusses a user's positive experience with a hair loss treatment routine involving dutasteride, oral minoxidil, and Nourkrin Man, with no side effects reported. Other users share their experiences with similar treatments, discussing side effects like heart palpitations and depression, and offer advice on obtaining prescriptions affordably.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Fin min micro 2 years. Last pic is for proof fin doesn’t ruin your muscle gains
The conclusion of the conversation is that the user, ZadarskiDrake, has been using minoxidil and finasteride for two years to treat hair loss. They apply minoxidil at night and have not experienced negative effects on muscle gains. They also mention using a needle pin for hair treatment.
community Why should more people explore the "new frontiers" of treatment (Megathread).
The conversation discusses exploring new hair loss treatments beyond popular ones like Finasteride, Minoxidil, and Ketoconazole. Specific treatments mentioned include ozone therapy, Dutasteride mesotherapy, RegeneraActiva, microcurrent electrical hair stimulation, Nourkrin, and BioEqua Enercharger.
community Dutasteride + oral minoxidil: strong regrowth by Jan 2026, then mid-scalp density loss without current shedding
The user experienced hair regrowth with dutasteride and oral minoxidil from October 2025 to January 2026, but mid-scalp density decreased afterward despite continued treatment. Ketoconazole improves scalp condition, but stopping it worsens hair appearance.
community Dutasteride + Oral Minoxidil results so far
The user reported improved hair density using Dutasteride 0.5mg and Oral Minoxidil 3.75mg, along with Nizoral shampoo and oils. There was debate about the validity of the progress due to differences in lighting and angles in the photos.
community Dutasteride + Oral minoxidil progress pictures
Dutasteride and oral minoxidil significantly improved hair appearance, with noticeable changes in color and texture. The user experienced minimal side effects and attributes most progress to dutasteride.
Related Research
6 / 6 results
research Prostaglandin F2α stimulates the growth of human intermediate hair follicles in ex vivo organ culture with potential clinical relevance
This study demonstrated that PGF 2α significantly stimulates hair growth in human hair follicles via a receptor-driven mechanism, with a notably stronger response in intermediate follicles than in terminal ones, suggesting potential clinical significance for conditions like alopecia.
research A Canadian Consensus on Androgenetic Alopecia: Approach and Management
This expert panel review developed consensus recommendations for managing androgenetic alopecia in Canadian adults, endorsing seven interventions like oral and topical medications and platelet-rich plasma.
research Interventions for female pattern hair loss
This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.
research Interventions for female pattern hair loss
This review found evidence supporting the effectiveness and safety of topical minoxidil for treating female pattern hair loss, though many included studies were at high risk of bias.
research Providing mesotherapy to prevent and treat hair loss in aesthetic practice
This article provides descriptive results indicating high client satisfaction and good tolerance associated with mesotherapy in treating hair loss, based on the author's personal experience with clients.
research 32571 Intensive dutasteride mesotherapy protocol (IDMP) with oral minoxidil as an alternative to antiandrogens in AGA. A retrospective analysis of a hair restoration center
In this study, the authors highlight the potential of intradermal microinjections of dutasteride as an adjunctive therapy for androgenetic alopecia, though they note that information on its effectiveness remains limited.